PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Company ReportsXellia
Xellia
Xellia ApS is a Danish multinational pharmaceutical and life sciences company headquartered in Copenhagen specialized in the production of anti-biotics, including Vancomycin and Bacitracin.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
CaspofunginCaspofungin2018-07-022032
ColistimethateColistimethate2015-05-29
DaptomycinDaptomycin2016-06-152028-2041
MicafunginMicafungin2021-06-02
Polymyxin bPolymyxin b2014-01-15
TigecyclineTigecycline2019-10-182026-2033
TobramycinTobramycin2014-09-162024-2030
VancomycinVancomycin2015-09-092035
Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use